NIH Awards $24.5M for Biomedical Clinical Trial on Systolic Blood Pressure
Contract Overview
Contract Amount: $24,519,297 ($24.5M)
Contractor: University of Utah
Awarding Agency: Department of Health and Human Services
Start Date: 2009-09-15
End Date: 2019-03-21
Contract Duration: 3,474 days
Daily Burn Rate: $7.1K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 15
Pricing Type: COST NO FEE
Sector: R&D
Official Description: BIOMEDICAL CLINICAL TRIAL TO STUDY SYSTOLIC BLOOD PRESSURE
Place of Performance
Location: SALT LAKE CITY, SALT LAKE County, UTAH, 84112
State: Utah Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $24.5 million to UNIVERSITY OF UTAH for work described as: BIOMEDICAL CLINICAL TRIAL TO STUDY SYSTOLIC BLOOD PRESSURE Key points: 1. Significant investment in critical health research. 2. Competition method suggests potential for fair pricing. 3. Long duration may indicate complex research scope. 4. Focus on R&D aligns with agency mission.
Value Assessment
Rating: good
The contract value of $24.5M over 10 years for a clinical trial is within a reasonable range for complex biomedical research. Benchmarking against similar large-scale, multi-year clinical trials would provide a more precise assessment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
Full and open competition was utilized, which typically fosters competitive pricing and ensures the best value is obtained. The agency likely received multiple proposals, allowing for price discovery and selection of the most cost-effective approach.
Taxpayer Impact: Taxpayer funds are being directed towards potentially impactful health research, with the expectation of a return on investment through improved public health outcomes.
Public Impact
Advancement of medical knowledge in cardiovascular health. Potential for new treatments or interventions for hypertension. Supports academic research and scientific innovation.
Waste & Efficiency Indicators
Waste Risk Score: 70 / 10
Positive Signals
- Supports critical health research.
- Utilized full and open competition.
- Long-term investment in scientific advancement.
Sector Analysis
This contract falls under Research and Development in the Physical, Engineering, and Life Sciences. Spending in this sector is crucial for innovation and addressing societal challenges, with significant government investment aimed at scientific breakthroughs.
Small Business Impact
The data does not indicate specific subcontracting opportunities for small businesses. Further analysis would be needed to determine if small businesses were involved or could have been engaged.
Oversight & Accountability
The contract was awarded by the Department of Health and Human Services, National Institutes of Health, suggesting established oversight mechanisms for research grants and contracts. The long duration implies ongoing monitoring.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Long contract duration may increase risk of scope creep or changing research needs.
- Complexity of clinical trials can lead to unforeseen costs.
- Reliance on a single awardee for a decade requires strong performance monitoring.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, ut, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $24.5 million to UNIVERSITY OF UTAH. BIOMEDICAL CLINICAL TRIAL TO STUDY SYSTOLIC BLOOD PRESSURE
Who is the contractor on this award?
The obligated recipient is UNIVERSITY OF UTAH.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $24.5 million.
What is the period of performance?
Start: 2009-09-15. End: 2019-03-21.
What is the expected impact of this trial on public health guidelines?
The trial aims to study systolic blood pressure, a key indicator of cardiovascular health. Findings could lead to updated clinical guidelines for managing hypertension, potentially improving patient outcomes and reducing healthcare costs associated with heart disease and stroke.
What are the primary risks associated with a long-term clinical trial of this nature?
Risks include potential for participant attrition, unexpected scientific challenges, changes in medical best practices during the trial, and budget overruns. Ensuring robust data collection and adaptive trial management are crucial to mitigate these risks.
How effectively does this contract align with NIH's strategic research priorities?
This contract directly aligns with NIH's mission to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, particularly in the area of cardiovascular disease.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 15
Pricing Type: COST NO FEE (S)
Evaluated Preference: NONE
Contractor Details
Address: 201 PRESIDENTS CIR RM 408, SALT LAKE CITY, UT, 84112
Business Categories: Category Business, Educational Institution, Government, Higher Education, U.S. National Government, Not Designated a Small Business, Higher Education (Public), U.S. Regional/State Government
Financial Breakdown
Contract Ceiling: $24,519,297
Exercised Options: $24,519,297
Current Obligation: $24,519,297
Contract Characteristics
Multi-Year Contract: Yes
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Timeline
Start Date: 2009-09-15
Current End Date: 2019-03-21
Potential End Date: 2019-03-21 00:00:00
Last Modified: 2024-08-22
More Contracts from University of Utah
- Nemsis Technical Assistance Center to Obtain a 24 Month Contract to Support Nemsis Database During a Transition From ITS Current Grantee to a NEW Contractor — $44.4M (Department of Transportation)
- Screening of Investigational Therapeutics to Treat, Modify or Prevent Epilepsy for the Ninds Epilepsy Therapy Screening Program (etsp) — $26.5M (Department of Health and Human Services)
- Identification and Characterization of Novel Therapeutics for the Treatment and Prevention of Epilepsy — $25.9M (Department of Health and Human Services)
- Other Functions Ninds Epilepsy Therapy Screening Program — $22.6M (Department of Health and Human Services)
- Biomedical (applied/Exploratory) — $20.6M (Department of Health and Human Services)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →